Related Experiment Video
Updated: Aug 11, 2026

07:41
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
Published on: January 18, 2019
Acetylcholine responses on clonal myogenic cells in vitro
The Journal of Physiology
|May 1, 1975
Summary
Electrophysiological studies reveal distinct acetylcholine responses in rat muscle cells. Myoblasts exhibit a slow hyperpolarizing response, while myotubes show a fast depolarizing response involving sodium, potassium, and calcium ions.
Area of Science:
- Neuroscience
- Cell Biology
- Muscle Physiology
Background:
- Electrophysiological properties of acetylcholine (ACh) receptors are crucial for understanding muscle function.
- Clonal rat myogenic cells provide a model system for studying muscle development and response.
- Differentiating between myoblast and myotube responses is key to understanding neuromuscular transmission.
Purpose of the Study:
- To investigate the electrophysiological characteristics of acetylcholine responses in clonal rat myogenic cells.
- To compare the ACh response in mononucleate myoblasts versus multinucleate myotubes.
- To determine the ionic basis and ion dependency of these responses.
Main Methods:
- In vitro electrophysiological recordings of clonal rat myogenic cells.
- Voltage-clamp techniques to analyze ion channel activity.
- Manipulation of external ion concentrations to determine reversal potentials.
Main Results:
- Mononucleate myoblasts displayed a slow, hyperpolarizing ACh response.
- Multinucleate myotubes exhibited a fast, depolarizing ACh response, mimicking mammalian skeletal muscle.
- The depolarizing response involved sodium (Na+), potassium (K+), and calcium (Ca2+) ions, but not chloride (Cl-) ions.
- Reversal potentials showed similarities to frog muscle but with quantitative differences.
Conclusions:
- Rat myogenic cells differentiate in their electrophysiological response to acetylcholine.
- Myotubes possess functional acetylcholine receptors mediating a depolarizing response essential for muscle contraction.
- The ionic mechanisms of the myotube response are conserved but show species-specific quantitative variations.
Related Concept Videos
Muscle Contraction
Muscle Contraction
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive muscle...
Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

